(R)-N-(1-(3-amino-4,5-dichlorobenzo[d]isoxazol-7-yl)pyrrolidin-3-yl)-2-chloro-4-(4H-1,2,4-triazol-4-yl)benzamide

ID: ALA4072364

PubChem CID: 118456975

Max Phase: Preclinical

Molecular Formula: C20H16Cl3N7O2

Molecular Weight: 492.75

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1noc2c(N3CC[C@@H](NC(=O)c4ccc(-n5cnnc5)cc4Cl)C3)cc(Cl)c(Cl)c12

Standard InChI:  InChI=1S/C20H16Cl3N7O2/c21-13-5-11(30-8-25-26-9-30)1-2-12(13)20(31)27-10-3-4-29(7-10)15-6-14(22)17(23)16-18(15)32-28-19(16)24/h1-2,5-6,8-10H,3-4,7H2,(H2,24,28)(H,27,31)/t10-/m1/s1

Standard InChI Key:  QZGGHXGKNNVCFF-SNVBAGLBSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   21.2951  -16.8638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2939  -17.6834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0020  -18.0923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7116  -17.6829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7088  -16.8602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0002  -16.4550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5873  -16.4554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5871  -15.6382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8797  -16.8642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1719  -16.4557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0858  -15.6441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2865  -15.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8780  -16.1822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4250  -16.7893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0673  -16.2696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5872  -15.6070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7753  -15.6922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4424  -16.4395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7378  -17.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9240  -17.1063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7605  -17.9088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4733  -18.3123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0772  -17.7591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0168  -18.2475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9978  -15.6378    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   23.4200  -18.0904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5072  -18.9005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3068  -19.0692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7143  -18.3608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1665  -17.7544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6295  -16.5237    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.2950  -15.0310    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
 10  9  1  1
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 20  1  0
 19 15  1  0
 13 15  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 21 24  1  0
  6 25  1  0
  4 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 18 31  1  0
 17 32  1  0
M  END

Associated Targets(Human)

F9 Tchem Coagulation factor IX (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 492.75Molecular Weight (Monoisotopic): 491.0431AlogP: 3.96#Rotatable Bonds: 4
Polar Surface Area: 115.10Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.51CX LogP: 2.67CX LogD: 2.67
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.74

References

1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S..  (2017)  Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.,  27  (11): [PMID:28408226] [10.1016/j.bmcl.2017.03.002]

Source